Log in to save to my catalogue

The bioavailability time of commonly used thymidine analogues after intraperitoneal delivery in mice...

The bioavailability time of commonly used thymidine analogues after intraperitoneal delivery in mice...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10411052

The bioavailability time of commonly used thymidine analogues after intraperitoneal delivery in mice: labeling kinetics in vivo and clearance from blood serum

About this item

Full title

The bioavailability time of commonly used thymidine analogues after intraperitoneal delivery in mice: labeling kinetics in vivo and clearance from blood serum

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Histochemistry and cell biology, 2022-02, Vol.157 (2), p.239-250

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Detection of synthetic thymidine analogues after their incorporation into replicating DNA during the S-phase of the cell cycle is a widely exploited methodology for evaluating proliferative activity, tracing dividing and post-mitotic cells, and determining cell-cycle parameters both in vitro and in vivo. To produce valid quantitative readouts for i...

Alternative Titles

Full title

The bioavailability time of commonly used thymidine analogues after intraperitoneal delivery in mice: labeling kinetics in vivo and clearance from blood serum

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10411052

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10411052

Other Identifiers

ISSN

0948-6143

E-ISSN

1432-119X

DOI

10.1007/s00418-021-02048-y

How to access this item